Mary Hanessian
Psychiatry · Athens, OHNPI 1508003294
Payments from drug & device makers
Across 221 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$562
- Axsome Therapeutics, Inc.$273
- Alkermes, Inc.$262
- Lundbeck LLC$247
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$232
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,89199%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $1,160 |
| Otsuka America Pharmaceutical, Inc. | 27 | $562 |
| Axsome Therapeutics, Inc. | 9 | $273 |
| Alkermes, Inc. | 14 | $262 |
| Lundbeck LLC | 15 | $247 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $232 |
| Teva Pharmaceuticals USA, Inc. | 14 | $225 |
| Neurocrine Biosciences, Inc. | 10 | $168 |
| Johnson & Johnson | 9 | $160 |
| Supernus Pharmaceuticals, Inc. | 9 | $147 |
| Sunovion Pharmaceuticals Inc. | 10 | $116 |
| Indivior Inc. | 6 | $114 |
| Corium, LLC | 4 | $78 |
| Ironshore Pharmaceuticals Inc. | 4 | $70 |
| Jazz Pharmaceuticals Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Tris Pharma Inc | 1 | $17 |
| Neos Therapeutics, LP | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
How this compares
$3,941 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 33 | $279,131 |
| AustedoDeutetrabenazine | 25 | $243,693 |
| VraylarCariprazine Hcl | 77 | $113,435 |
| RexultiBrexpiprazole | 64 | $91,635 |
| LybalviOlanzapine/Samidorphan Malate | 37 | $56,070 |
| AuvelityDextromethorphan Hbr/Bupropion | 62 | $40,748 |
| CaplytaLumateperone Tosylate | 22 | $34,931 |
| TrintellixVortioxetine Hydrobromide | 67 | $32,904 |
| Lurasidone Hcl | 36 | $14,372 |
| VyvanseLisdexamfetamine Dimesylate | 19 | $7,182 |
| Adderall XrDextroamphetamine/Amphetamine | 11 | $4,569 |
| Clorazepate Dipotassium | 55 | $4,550 |
| Lisdexamfetamine Dimesylate | 23 | $4,307 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 52 | $4,112 |
| Ondansetron Hcl | 13 | $3,861 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $168 | $279,13133 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $225 | $243,69325 claims |
| AbbVieVraylar | $1,160 | $113,43577 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $562 | $91,63564 claims |
| Alkermes, Inc.Lybalvi | $262 | $56,07037 claims |
| Axsome Therapeutics, Inc.Auvelity | $273 | $40,74862 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $33 | $40,08686 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $232 | $34,93122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Athens
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
- Richard SandersDayton$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.